51282
Deoxyfuconojirimycin hydrochloride
≥98.0% (TLC)
Synonym(s):
1,5-Dideoxy-1,5-imino-L-fucitol hydrochloride
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
Assay
≥98.0% (TLC)
SMILES string
Cl.C[C@@H]1NC[C@@H](O)[C@H](O)[C@@H]1O
InChI
1S/C6H13NO3.ClH/c1-3-5(9)6(10)4(8)2-7-3;/h3-10H,2H2,1H3;1H/t3-,4+,5+,6-;/m0./s1
InChI key
SHSBWMUIVLOMIL-NQZVPSPJSA-N
Biochem/physiol Actions
Deoxyfuconojirimycin is a specific and competitive inhibitor of human liver α-L-fucosidase.
Packaging
Bottomless glass bottle. Contents are inside inserted fused cone.
Other Notes
To gain a comprehensive understanding of our extensive range of Monosaccharides for your research, we encourage you to visit our Carbohydrates Category page.
Storage Class Code
13 - Non Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Cell surface associated alpha-L-fucose moieties modulate human breast cancer neoplastic progression.
Pathology oncology research : POR, 14(2), 145-156 (2008-06-17)
Glycosylation drives critical processes important for mammalian cell-cell and cell-matrix interactions. Alpha-L-fucose (alpha-L-f) is a key monosaccharide component of oligosaccharides that has been found to be overexpressed during tumor progression. Modification of cell surface fucosylation, we hypothesized, alters tumor cell
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service